ADBE

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

–

Return

+0.51%

Status

scored

The three analysts converge on Underweight direction, with the correct synthesis being a 10-15% immediate trim at ~$241 targeting 65-75% of benchmark weight as residual UW stance, supported by a hard stop at $226 on volume >4M shares and structural re-engagement above $268; no synthetic hedge recommended, as the trim itself creates dry powder for re-engagement at lower levels or rotation to less rate-sensitive software, with the 60-90 day horizon extending through Q4 FY26 earnings in mid-December and the Dec 1 CEO transition.

Outcome

✗

Return

+3.56%

Status

scored

Underweight rating maintained on ADBE with immediate 25-30% trim at current ~$232, capping residual at 50% of pre-trim weight with hard stop at $226 and re-engagement only above $265 on 3-of-5 confirmations including structural signals; no synthetic hedge, using trim proceeds as dry powder instead. The bear case is directionally unanimous but analysts over-shoot on trim magnitude and execution timing—the fortress floor (89% gross margins, 0.18x net debt/EBITDA, $9-10B buyback) warrants a smaller, faster trim rather than waiting for the $243-258 resistance zone that historically fails to materialize.

Outcome

✓

Return

-2.25%

Status

scored

Trim 25-30% of ADBE over 1-2 weeks using limit orders at $242-246 rather than waiting for a $255-258 rally that is unlikely given the stock's five-week grinding decline and rejection at the 50/200 SMA cluster. Maintain a hard stop at $226 on a daily close with volume exceeding 4M shares, and reassess to Hold if the stock closes above $265 on elevated volume. Do not initiate a tactical short given the $9-10B buyback program and fortress fundamentals (8.6x forward P/E, 0.18x net debt/EBITDA, 89% gross margins).

Outcome

✓

Return

-0.28%

Status

scored

Maintain existing 1-2% ADBE equity exposure without adding at current levels, layering in a 0.5-1% cash-secured put overlay at $200 strike (Dec/Jan expiry) for 3-5% yield on notional while waiting, and replacing outright protective puts with $210/$190 put spreads to cut hedge cost ~50%. Pre-commit to mechanical triggers governing position adjustments, with reassessment at Q4 FY26 print in late December.

Outcome

✓

Return

+0.46%

Status

scored

Maintain Adobe at current exposure without aggressive addition at $237, given the confirmed downtrend and broken chart structure despite anomalous valuation (8.6x forward P/E, 9.9% FCF yield). Two explicit scale-in triggers are defined: a confirmed break above the 50 SMA at $258 with positive MACD crossover (50% weight), or a retest of the June low at $190-$195 (full weight), with hard stop at $190. The Q4 FY26 print (~10 weeks out) serves as the binary catalyst to resolve current uncertainty.

Outcome

✓

Return

-1.49%

Status

scored

Trim ADBE exposure by 30-40% in three tranches: 15-20% at current levels near $241, 10-15% on retest of $249-250, and 5-10% on confirmed break below $231 with volume >7M shares. The stop is widened to $268 (rather than $260) to account for the 9.33 ATR — $260 is deemed noise on a high-volatility name. Do not initiate new longs or short the name given fortress fundamentals (0.18x net debt/EBITDA, $11.28B annual buyback), and reassess at mid-November technical confirmation and mid-December Q4 FY26 print with Dec 1 CEO transition.

Outcome

✓

Return

+0.56%

Status

scored

Initiate a disciplined Overweight probe at $235-240 with 25% of target weight (~0.6% of portfolio), tighter stop at $225, and reserve 75% of dry powder for staged confirmation-based adds at $225-230 with RSI divergence, 10 EMA reclaim at $241.25 with RSI >50, and post-Q4 FY26/CEO transition; the $275 price target (6-21% upside from $240) reflects bear-adjusted fair value while respecting the 9/29 lesson against initiating at valuation gap without technical or fundamental confirmation.

Outcome

✗

Return

+2.90%

Status

scored

Maintain ADBE position at current levels with no additions at $233 and no aggressive trims, as the attractive valuation (8.4x forward P/E, 0.56 PEG, 10% FCF yield) lacks confirmed entry triggers given deteriorating operating reality (revenue growth velocity -38% QoQ, 300bps margin compression). The $10B FCF, 89% gross margins, and ~$35M/day buyback program create a fortress floor that absorbs bear-case pressure, making Hold the correct posture while awaiting either RSI bullish divergence with close above $241 or 50 SMA reclaim at $257 on volume above 6.5M shares before any directional sizing changes.

Outcome

✓

Return

+0.94%

Status

scored

Overweight ADBE with a disciplined three-tranche entry strategy: initial 25% position in the $224-228 zone with hard stop at $214.50, requiring 5-10% OTM 3-month puts as mandatory portfolio insurance and explicit technical invalidation rules (MACD < -3.40 or RSI < 30 without divergence = cut regardless). Tranches 2 and 3 (each 25%) trigger only on confirmed 10 EMA reclaim at $243.40 with MACD contraction and volume >6M, then 50 SMA close at $257.29 with RSI >50. Trim points at $257, $290, with remaining 50% trailed on 50 SMA toward $310-320 target; pre-committed re-assessment at mid-November deadline and mid-December Q4 FY26 print.

Outcome

✗

Return

-1.89%

Status

scored

Overweight ADBE on extreme valuation asymmetry (8.5x forward P/E with 12.9% revenue growth, 88.7% gross margins, 10% FCF yield) that forces a directional flip from the prior Underweight sequence. Position sized at 2% initial with disciplined staged adds on technical confirmation (higher low above $235.47 with RSI>40, or break above 50 SMA at $257.42 on volume), hard stop at $190.12, and pre-committed reassessment at mid-November and mid-December (Q4 FY26 print + CEO transition). The rating is capped at Overweight rather than Buy due to binding lessons from the failed 9/21 Overweight attempt, hostile technical stack, and binary catalysts that could invalidate the thesis.

Outcome

✓

Return

-1.45%

Status

scored

The Portfolio Manager recommends trimming 40-50% of ADBE exposure over 4-6 weeks, citing broken forward P/E math, bearish technicals (price below all major moving averages, MACD at -5.89, RSI at 38), and sustained macro headwinds with the 10Y at 2007 highs. While the cash flow floor ($10B FCF, 89% gross margins) supports Underweight over a hard Sell, the position sizing should be aggressive per the 9/23 binding lesson, and options overlays are recommended to manage residual exposure.

Outcome

✓

Return

-0.73%

Status

scored

Underweight ADBE with 40-50% position reduction recommended. Trim tranche one at 25% into opening weakness, with tranche two at 15-25% on relief rally toward $257 or hard time-stop at ~30 trading sessions. Hard stop-line at $228.51 (lower Bollinger Band) caps residual exposure, with total ADBE weight capped at 50% of benchmark.

Outcome

✗

Return

+1.02%

Status

scored

Maintain Underweight on ADBE with 40-50% position reduction executed in tranches—30% at current levels and 15-20% on close below $231 or failed 10-EMA retest at $252—targeting $220 over a 3-4 month horizon through the Q4 FY26 print (mid-December) and Dec 1 CEO handoff; firm stop at $227 with conditional tightening to $235 on confirmed lower-band break on volume >7M. Key bear pillars are broken forward EPS math (implied 55% growth on flat sequential revenue), confirmed technical downtrend (price below 10-EMA/50-SMA/200-SMA, embryonic death cross, RSI 37), shifted macro regime (Fed hike, 96% no-cut probability, 1.42-beta), and $31.3M insider Narayen sale during third weekly loss; re-engagement triggers are capitulation-volume flush to $200-209 or MACD bullish cross with close >$256.

Outcome

✗

Return

-4.52%

Status

scored

Overweight ADBE with measured execution at 30-35% initial sizing at $248-252, stop at $228 (max 15% drawdown). Tiered adds on 200 SMA reclaim ($264.62 with >6.5M volume), MACD bullish cross above 200 SMA, and final 15-20% on Q4 ARR inflection or successful Dec 1 CEO handoff. Hard reassessment trigger by mid-November if neither technical confirmation nor insider accumulation emerges, with Underweight reassessment if close <$235 on >7M volume.

Outcome

–

Return

+0.24%

Status

scored

Underweight ADBE with trim-on-bounce execution: reduce existing longs 15-25% into $260-270 resistance zone rather than chase the broken-entry Sell escalation at $266.50; tactical failed-rally shorts into $260-265 with stops above $274 and targets at $238/$225/$204 are defensible at 1-2% sizing. Reject Sell escalation not because the bearish thesis is wrong, but because the trader's order ticket is structurally broken (7% chase into resistance with 10.7% actual risk vs framed 3.5%), and the $245 structural floor with $11B annual buyback and 0.18x net debt/EBITDA warrants respect per the 9/11 binding constraint.

Outcome

✓

Return

-1.48%

Status

scored

Maintain ADBE at benchmark weight with no fresh capital deployment; move hard stop to $232 (below $245 confluence zone and June $237 swing low), restructure collar closer to the money (sell $265-275 call spread, buy $245-235 put spread), and pre-commit to decisive re-rating at mid-December Q4 FY26 print rather than running the Hold thesis open-ended in deteriorating macro conditions.

Outcome

✓

Return

+0.87%

Status

scored

Overweight rating on ADBE at ~$250.50 with measured tiered execution: initial 10-15% add with stop at $235, followed by tiered adds on 200 SMA reclaim ($265.70), MACD histogram turn positive, and ARR/CEO catalysts; income overlay via cash-secured puts at $230-235 strike to monetize elevated IV; upside targets $280/$294/$310 with 25% trim at first target, and pre-committed Q4 FY26 print review (mid-December) as resolution catalyst.

Outcome

✓

Return

-2.82%

Status

scored

Maintain ADBE exposure at $257.76 with a defined-downside hedge structure (sell $275-285 call spread, buy $240-220 put spread) to address time-decay cost without taking a directional Underweight bet that requires the 50 SMA floor at $254.32 to break for vindication. Bullish trigger for 25% add: close >$267 on >6.5M volume; bearish trigger for 25-50% trim: close <$254 on >7M volume; inaction remains the disciplined default until a trigger fires.

Outcome

✓

Return

-2.95%

Status

scored

Maintain ADBE at Hold with no fresh capital deployment at current levels ($265.60). The 50 SMA structural floor ($253.53) remains intact with $11.28B FY25 buyback support, $6.91B deferred revenue, and 9.6x forward P/E, while the failed 200 SMA test ($266.10 intraday high vs $266.34 SMA) prevents Overweight initiation. The $253-$267 chop zone warrants inaction until either a close above $267 on >6.5M volume (bullish trigger) or below $253 on >7M volume (bearish trigger) resolves the technical uncertainty.

Outcome

✗

Return

+5.30%

Status

scored

Maintain Underweight on ADBE while trimming 15-25% of existing exposure at current ~$252 spot (not the stale $268 level), with a smaller trim closer to 10% rather than 20%, waiting for confirmed close below $241.52 with volume rather than acting on a single SMA loss; hard stop on residual at $240 close over the 2-4 week horizon through CEO strategy reveal and CPI/Fed catalyst cluster.

Outcome

✗

Return

+1.37%

Status

scored

Underweight ADBE with a 15-20% measured trim ahead of the Sept 16 FOMC, converting residual into a collar structure (sell $275-285 call spread, buy $240-220 put spread) to define downside through the binary catalyst; hard stop on residual at $235 close. Post-Fed re-entry requires either closing above the $251.78 50 SMA with MACD stabilization, a flush to $235-244 with RSI bullish divergence, or reclaiming the $266.96 200 SMA on volume exceeding 6M.

Outcome

✓

Return

-2.37%

Status

scored

Analysts recommend maintaining ADBE at current levels with no new capital deployment before the September 10 earnings event, while allowing a bounded 10%-15% reduction only if a confirmed relief bounce to $267-$271 materializes—preferably on weak volume. The fundamental case remains intact with ~9.3x forward P/E and strong FCF metrics ($9.22B trailing, 36.6% margin), but unfavorable technicals (below both 10-day EMA at $271.26 and 200-day SMA at $267.28, negative MACD at -4.15) combined with earnings risk and margin pressures warrant a cautious hold until post-event reassessment on a clean beat-and-raise and close above $271.

Outcome

✓

Return

-0.93%

Status

scored

Maintain Hold on Adobe into the September 10 binary print, as the structural floor at the 50 SMA ($249.94) remains intact while the 9.4x forward P/E, 0.65 PEG ratio, and 9% FCF yield provide compelling valuation support against liquidation. Convert the existing $275-285 naked call spread to a collar or paired put-spread structure to cap downside at approximately $220, as the symmetric risk profile of a binary catalyst with stacked negatives makes the current hedge structure inadequate. Reassess post-print based on three bifurcated scenarios, with no-trade directives for both adds and trims until Q3 FY26 print, CPI/PPI, and Fed decision all resolve within the 2-3 week window.

Outcome

✗

Return

-3.47%

Status

scored

Maintain Hold on Adobe as the 9/3 ADBE reflection is binding against fresh long exposure at $266, since the 200 SMA floor at $267.93 has been breached on above-average distribution volume — the lesson explicitly rejects defending broken floors. The conservative analyst's 40-50% trim is also rejected per 8/17 and TMO lessons, as the 50 SMA at $248 is the proper exhaustion zone; the Q3 FY26 print (~6 sessions out) is the decisive catalyst that will determine whether to upgrade to Overweight or downgrade to Underweight.

Outcome

✗

Return

-6.73%

Status

scored

Maintain ADBE at current residual weight (post-9/2 trim) with no further action—neither trim nor fresh adds—until Q3 FY26 print resolves the binary catalyst in ~2 weeks; the 9/2 Underweight outcome (+2.1%/+1.1% alpha) is binding precedent against trimming at this identical $285.75 price level with structural floor ($268.23 200 SMA, 10.4x P/E, 89% gross margins) intact. Hard stop remains $268 close; no hedge structure entered pre-print due to elevated two-way vol; if floor breaks pre-print exit fully and reassess at $250 zone.

Outcome

✗

Return

+2.13%

Status

scored

Trim ~20% of ADBE exposure at current ~$285 levels ahead of the Q3 FY26 print, with a hard stop on the residual position at $268 (~1.5 ATR below 200 SMA) and a 2-3% portfolio weight cap. The Underweight rating balances the aggressive analyst's correct directional call on deteriorating technicals (MACD collapse, failed Bollinger Band retest) against the conservative analyst's binding structural-floor defense (8.3% FCF yield, 62.9% ROE, 89% gross margins, ~5-6% buyback yield), with the BKNG/TMO cross-ticker lessons dispositive on magnitude. Use a tiered re-entry framework anchored to $268-272 support hold and $250 zone rather than a single price target or a collar with no defined trigger.

Outcome

✓

Return

-2.20%

Status

scored

Maintain ADBE at current exposure without adding fresh capital at ~$286, as the $292-295 supply zone needs absorption and the 50/200 SMA golden cross remains unconfirmed. Tier 1 add of 25-33% normal size is gated on pullback to $278-280 or confirmed golden cross/$294.50 breakout; $268 hard stop remains in place. Q3 FY26 earnings is the decisive near-term catalyst that will determine whether to upgrade to Overweight (targeting $310-320) or maintain Hold.

Outcome

✗

Return

-2.29%

Status

scored

Overweight rating with staged three-tranche framework targeting 60-70% of full weight: initiate ~1/3 at $289, add 1/3 on $269-$277 pullback holding, add final 1/3 on confirmed close above $294.13 with volume >7M. Hard stop $258 close (~3.2x ATR). Base target $320 / stretch $340 over 6-9 months; trim 20-25% into $310-$320 strength ahead of Q3 FY26. Reassess post-Q3 print—upgrade to Buy if operating margin holds above 33% and forward EPS stabilizes; downgrade to Hold if EPS cuts exceed 5%.

Outcome

✗

Return

+0.44%

Status

scored

Trim 25-30% of the existing ADBE position into the $290-295 resistance zone where the 61.8% Fibonacci retracement of the $370→$190 decline, RSI 68.8, and light-volume (3.64M vs ~5M average) Bollinger upper band test converge, reverting from Overweight to Underweight. Do not chase the $291 breakout; re-evaluation is triggered only at $255-265 on confirmed 200 SMA ($269) retest holding with declining volatility and stabilizing RSI. Q3 FY2026 earnings (mid-September) is the decisive catalyst—operational margin stabilization supports revisiting Overweight at $280-290, while further compression opens downside to $220-240.

Outcome

✓

Return

+0.82%

Status

scored

Analysts recommend building Overweight exposure in three tranches—40-50% at the $275-280 zone initially, then 25-30% on a confirmed close above $300 with volume >4M shares and MACD histogram >+0.50, and 25-30% on a pullback to the $269-273 10 EMA zone—while maintaining a hard stop at $254 close. The $340-360 target over 6-12 months reflects mean reversion to ~12-13x forward P/E on confirmed AI monetization inflection and Q3 margin stabilization, with a plan to trim 20-25% into $310-320 strength ahead of the Q3 FY26 binary catalyst.

Outcome

✗

Return

+5.73%

Status

scored

Maintain ADBE at neutral weight (≤2% of portfolio) using a tiered, confirmation-gated approach rather than passive drift or chasing into resistance. Tier 1 adds are triggered at $258-$264 only on confirmed MACD reset and 10 EMA stabilization, while Tier 2 adds at $246-$250 are reserved for broader market selloffs, with a hard stop at $240 close below the lower Bollinger Band and structural invalidation level.

Outcome

✓

Return

-0.16%

Status

scored

Portfolio managers maintain HOLD on Adobe at neutral weight with a tight $263 stop loss (confluence of 10 EMA/200 SMA/VWMA), limiting risk to ≤2% of portfolio given 1.40 beta and binary Q3 FY26 catalyst. The $286 price target reflects 3-6 month mean reversion to ~12x forward P/E; optional protective puts on 25-33% of position in the $254-260 strike zone are recommended as a rational hedge, but post-earnings stop management—trailing to $273 on clean beat, honoring $263 stop on miss—is the decisive execution discipline.

Outcome

✗

Return

-0.85%

Status

scored

Initiate Overweight with a disciplined 3-tranche scale-in strategy at $276 (30-35% weight), targeting $295-310 over 3-6 months; Tranche 2 triggers on confirmed $280 close above $4M volume with MACD histogram >+0.25, Tranche 3 on pullback to $258-262 holding the 20-day EMA, with hard stop at $244 and pre-earnings trim at $295-300.

Outcome

–

Return

+0.35%

Status

scored

Maintain Overweight on ADBE via a disciplined 3-tranche scale-in strategy capping position at 4% max, targeting $295-310 with a hard stop at $252 close (~1.7x ATR). The rating reflects the structural floor from AI-driven fundamentals and $10B buyback support while respecting incomplete technical confirmation requiring the staged entry approach.

Outcome

–

Return

+1.13%

Status

scored

Maintain Overweight on ADBE via a disciplined 3-tranche scale-in, reducing Tranche 1 to 25-33% of target weight (vs. trader's proposed 50%) to honor the trader's own confirmation framework—2 of 3 thresholds met (2 sessions above 200 SMA vs. required 3; MACD histogram at +0.11 vs. required +0.25). Hard stop at $253.50 (~1.7x ATR), with price targets of $286, $310, and $340 over 3-6 months, balancing the 8/13 lesson (avoid chasing unconfirmed setups) against the 8/17 lesson (don't surrender asymmetric upside at 9x forward P/E).

Outcome

✓

Return

-0.09%

Status

scored

Maintain ADBE at neutral weight (Hold) at $272.47, rejecting both a trader's SELL at $255 with a $275 stop (deemed sub-2x ATR against $11.88 ATR name) and an Underweight call (higher-low sequence at $190→$212→$264→$272 not yet broken). The 8/17 Underweight lesson at $254 that forfeited +3.6% alpha controls this decision; valuation at 9.91x forward P/E with $10B annual buyback and BlackRock 10% accumulation provides structural floor support. Re-evaluate to Overweight on close >$275.80 above 5.5M shares; downgrade to Underweight on close <$231.22 on volume or >3% EPS cut; escalate to Sell below $212. Price target $286.00 with Q3 FY26 as decisive catalyst.

Outcome

✓

Return

+3.55%

Status

scored

Adobe's 9.57x forward P/E, 8.8% FCF yield, and AI revenue growth create a compelling hold case, but deploying fresh capital at $263 against $271.41 resistance with freshly negative MACD is unjustified. Maintain existing exposure while awaiting either confirmed breakout above $271.41 on >4M shares or a pullback to $235-245, with stops tightened to $250 for existing longs.

Outcome

✗

Return

+3.58%

Status

scored

Trim 40-50% of ADBE exposure now at $254 (30% immediately, additional 15-20% on close below $240 with volume or below $230), retaining residual long exposure to capture the 9x forward P/E anomaly while anchoring a hard stop at $230 close on the 50 SMA; monetize elevated implied vol by selling calls or buying puts against residual. Operating leverage turned negative (opex +15% YoY vs. operating income +3.1%) and macro headwinds (30-year yields at 19-year highs, ~85% no-cut probability) create structural multiple compression, but residual exposure is warranted given $10B annual buyback (~2.5% float/quarter) and intact higher-low sequence ($190 → $212 → $264).

Outcome

✓

Return

-3.78%

Status

scored

Trim ADBE exposure to 65-70% of core allocation now in the $262-$266 zone rather than waiting, with a protective stop widened to $288 on a closing basis above 4M volume (2.1x ATR), rejecting the tighter intraday stop. Pre-commit reload triggers at $230-$235 for flush accumulation or a close above $290 for breakout entry before the Q3 FY26 catalyst in 6-8 weeks.

Outcome

✗

Return

-2.39%

Status

scored

Initiate Overweight at 1.0-1.5% portfolio weight in 3 tranches, starting with 30% of intended size at ~$270 (reduced from standard 40% to acknowledge the 200 SMA rejection pattern), with a hard stop at $252 (~1.6x ATR below entry); deploy remaining 70% on confirmed daily close above $272.79 with volume >4M shares (35%) or pullback to $248-$255 with improving RSI (35%).

Outcome

✗

Return

+4.54%

Status

scored

Execute the ADBE bearish posture with urgency by trimming 35-40% of target weight immediately at $258-260, staging a second 15-20% trim into any retest of $268-273 (200 SMA rejection zone), targeting an end-state weight of 50-60% of benchmark. Hard stop at $228 (50 SMA / 2x ATR alignment) with reassessment post-Q3 FY26 earnings in mid-September.

Outcome

✓

Return

-1.88%

Status

scored

Underweight rating on ADBE calls for trimming 35-45% of existing exposure on any rally toward $268-273 (the 200 SMA rejection zone) with a hard mental stop at $278, while sizing fresh initiation at half benchmark weight; the setup reflects a decisively bearish technical pattern (200 SMA rejection at $273.68, RSI bearish divergence at 68.54, MACD rollover) combined with deteriorating fundamentals (Q2 margin compression from $2.42B to $2.24B operating income, $3.2B working capital swing) in a hostile macro environment (86% no-cut probability, 1.40 beta), though residual exposure is warranted given the 9.9x forward P/E anomaly, $9.22B FCF, and $10B annual buyback supporting the position.

Outcome

✓

Return

-3.39%

Status

scored

Maintain ADBE HOLD while implementing three risk-management refinements: replace the $260 hard stop with a trailing stop anchored to the 50 SMA at $230 (hard floor $207); pre-commit only 25% of add-on capital to a confirmed breakout above $278 with volume >4M shares (reserve 75% for retest or pullback to 50 SMA); and execute a 10-15% pre-earnings trim ahead of mid-September Q3 FY26 print. The fundamental case is compelling (12.7% YoY revenue growth, 9.93x forward PE, 0.64 PEG, $9.2B TTM FCF, 89% gross margin, 63% ROE) but price at $272.96 sitting below the 200 SMA at $274.13 means the tactical tape has not confirmed the structural re-rating, making a HOLD the appropriately balanced position until the $274–$278 zone resolves on a confirmed daily close.

Outcome

✓

Return

+2.92%

Status

scored

Execute a disciplined BUY at $258 using limit orders in the $258-265 range, starting with 35-40% sizing instead of 50% to account for four unresolved risk vectors: 200 SMA rejection at $274.55, six-session MACD histogram contraction, volume exhaustion on recent highs, and the Figma AI-cost narrative. Reserve 60-65% of intended weight for either a confirmed breakout above $274.55 on volume > 1.5x 7-day average or a pullback to $250-253 near the 10 EMA. Hard stop at $224 (below 50 SMA at $229.79). Targets are $295-300 first leg and $350-358 second leg over 6-12 months.